Pfizer : PFE

All Pfizer Articles

1482 Articles

Jon C. Ogg | Jul 11, 2014 at 7:40 AM EDT

Short Sellers Get Aggressive in Defensive High-Yield Dividend Stocks

The short interest data for the June 30 settlement date is out, and there were selectively an increasing number of…

Lee Jackson | Jul 7, 2014 at 8:55 AM EDT

New Stocks Added to Merrill Lynch Alpha Surprise List

Wikimedia CommonsThe Merrill Lynch team updated their Alpha Surprise stocks list for July, and they added some top stocks on…

Paul Ausick | Jul 2, 2014 at 4:01 PM EDT

The 4 Stocks That Confused the Market

thinkstockJuly 2, 2014: Markets opened mixed on Wednesday with the S&P 500 starting just barely in the red based on…

Paul Ausick | Jun 26, 2014 at 4:01 PM EDT

The 4 Stocks That Mired the Market

thinkstockJune 26, 2014: Markets opened lower for a fourth straight day on Thursday and spent much of the day trying…

Paul Ausick | Jun 25, 2014 at 4:01 PM EDT

The 4 Stocks That Drove the Market

thinkstockJune 25, 2014: Markets opened lower for a third straight day on Wednesday, but led by tech and healthcare stocks…

Jon C. Ogg | Jun 25, 2014 at 10:05 AM EDT

Short Interest Screams Higher in Defensive High-Yield Stocks

The short interest data for the first two weeks of June show that short interest was higher in almost all…

Trey Thoelcke | Jun 24, 2014 at 10:10 AM EDT

Merrill Lynch Says These Five Top Stocks to Buy Are Oversold

A new research report from Merrill Lynch documents some top stocks that have underperformed the overall market, some to the…

Paul Ausick | Jun 23, 2014 at 4:01 PM EDT

The 4 Stocks That Sank the Market

thinkstockJune 23, 2014: Markets opened mixed on Monday with the tech-heavy Nasdaq Composite starting the day with a small gain…

Trey Thoelcke | Jun 16, 2014 at 8:35 AM EDT

Deutsche Bank Prefers These Low P/E Stocks in a Market Correction

courtesy of Ford Motor CompanyTwo factors are about ready to collide, and if history is any guide, the outcome could…

Jon C. Ogg | Jun 11, 2014 at 11:45 AM EDT

Short Sellers Get Selective in High-Yield Defensive Dividend Stocks

ThinkstockThe short interest data for the final two weeks of May have been released, and the results are somewhat surprising…

Trey Thoelcke | Jun 11, 2014 at 8:55 AM EDT

Jefferies Franchise Picks: Highest Conviction Stocks to Buy Now

Wikimedia CommonsWith a very toppy market, and more than one firm on Wall Street warning of a potential summer sell-off,…

Jon C. Ogg | May 27, 2014 at 1:35 PM EDT

Pfizer’s Real Issue: Identity Crisis Against Peers

Pfizer looks like it is out of the bid now for AstraZeneca. What looks increasingly obvious for a lackluster performance…

Jon C. Ogg | May 27, 2014 at 8:55 AM EDT

The Dangers of Chasing Hopeful Merger and Buyout Stocks

ThinkstockEvery time the economy gets good again, and every time the stock market gets high again, waves of mergers and…

Trey Thoelcke | May 22, 2014 at 8:20 AM EDT

Why You Buy Big Pharma If the Market Crashes

A new report from the global equity strategy team at Credit Suisse maintains that the best defensive sector now is…

Jon C. Ogg | May 21, 2014 at 7:40 AM EDT

Dividend Shock: Over Half of DJIA Blue Chips Outyield 10-Year Treasury

Several things are taking place ahead of the end of May, and the number of pundits getting more worried about…

1 … 64 65 66 67 68 … 99

Pfizer : PFE

All Pfizer Articles

Short Sellers Get Aggressive in Defensive High-Yield Dividend Stocks

New Stocks Added to Merrill Lynch Alpha Surprise List

The 4 Stocks That Confused the Market

The 4 Stocks That Mired the Market

The 4 Stocks That Drove the Market

Short Interest Screams Higher in Defensive High-Yield Stocks

Merrill Lynch Says These Five Top Stocks to Buy Are Oversold

The 4 Stocks That Sank the Market

Deutsche Bank Prefers These Low P/E Stocks in a Market Correction

Short Sellers Get Selective in High-Yield Defensive Dividend Stocks

Jefferies Franchise Picks: Highest Conviction Stocks to Buy Now

Pfizer’s Real Issue: Identity Crisis Against Peers

The Dangers of Chasing Hopeful Merger and Buyout Stocks

Why You Buy Big Pharma If the Market Crashes

Dividend Shock: Over Half of DJIA Blue Chips Outyield 10-Year Treasury

The $10 Trillion Bet: Why Insiders Think SpaceX Could Rival Apple by Decade’s End

IBM Set Records, Delivered 44% Gains in a Single Month as Trump Clip Resurfaces

$8.5 Billion: Berkshire’s Greg Abel Just Made His First Big Bet, and It’s Wildly Contrarian

Why Social Security's 2.8% COLA Isn't Keeping Up With What Retirees Actually Spend on Healthcare

How Far Does $4,200 a Month Go in Retirement With No Mortgage but a $9,600 HOA?

Google vs. Microsoft: Which Cloud Giant Deserves Your Capital Right Now?

The $10 Trillion Bet: Why Insiders Think SpaceX Could Rival Apple by Decade’s End

Pfizer : PFE

All Pfizer Articles

Short Sellers Get Aggressive in Defensive High-Yield Dividend Stocks

New Stocks Added to Merrill Lynch Alpha Surprise List

The 4 Stocks That Confused the Market

The 4 Stocks That Mired the Market

The 4 Stocks That Drove the Market

Short Interest Screams Higher in Defensive High-Yield Stocks

Merrill Lynch Says These Five Top Stocks to Buy Are Oversold

The 4 Stocks That Sank the Market

Deutsche Bank Prefers These Low P/E Stocks in a Market Correction

Short Sellers Get Selective in High-Yield Defensive Dividend Stocks

Jefferies Franchise Picks: Highest Conviction Stocks to Buy Now

Pfizer’s Real Issue: Identity Crisis Against Peers

The Dangers of Chasing Hopeful Merger and Buyout Stocks

Why You Buy Big Pharma If the Market Crashes

Dividend Shock: Over Half of DJIA Blue Chips Outyield 10-Year Treasury

The $10 Trillion Bet: Why Insiders Think SpaceX Could Rival Apple by Decade’s End

IBM Set Records, Delivered 44% Gains in a Single Month as Trump Clip Resurfaces

$8.5 Billion: Berkshire’s Greg Abel Just Made His First Big Bet, and It’s Wildly Contrarian

Featured Reads

Why Social Security's 2.8% COLA Isn't Keeping Up With What Retirees Actually Spend on Healthcare

How Far Does $4,200 a Month Go in Retirement With No Mortgage but a $9,600 HOA?